Oaktree Acquisition Corp. III Life Sciences
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
OACC$10.70-0.2%Stored close · as of Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Part III. Signatures
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| OAKTREE ACQUISITION CORP. III LIFE SCIENCES | ||
| Date: May 14, 2025 | By: | /s/ Zaid Pardesi |
|---|---|---|
| Name: | Zaid Pardesi | |
| Title: | Chief Executive Officer | |
| (Principal Executive Officer) | ||
| Date: May 14, 2025 | By: | /s/ Courtney Conigliaro |
| Name: | Courtney Conigliaro | |
| Title: | Chief Financial Officer | |
| (Principal Financial and Accounting Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.